TRB Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$351K Sell
12,293
-11,096
-47% -$295K 0.05% 190
2026
Q2
$563K Sell
23,389
-3,921
-14% -$103K 0.08% 134
2026
Q1
$767K Buy
+27,310
New +$727K 0.11% 113

Other funds holding PFE

TRB Wealth Management's PFE Position: Q3 2026 in Review

TRB Wealth Management reduced its Pfizer (PFE) stake by 47% in Q3 2026, selling an estimated $295K and leaving 12,293 shares worth $351K. The position accounts for 0.05% of the portfolio, ranked #190.

TRB Wealth Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. The position peaked at $767K in Q1 2026. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • TRB Wealth Management held 12,293 shares of Pfizer worth $351K as of Q3 2026.
  • TRB Wealth Management sold 11,096 Pfizer shares in Q3 2026, an estimated $295K.
  • Pfizer made up 0.05% of TRB Wealth Management's portfolio in Q3 2026, its #190 holding.
  • TRB Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • TRB Wealth Management's Pfizer position peaked at $767K in Q1 2026.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.